Scientific Publications

Marinomed Biotech AG
News & Publications
Scientific Publications

ALL
2023
2022
2021
2020
2015

Virology Related

Biological activity of algal derived carrageenan: A comprehensive review in light of human health and disease

Pradhan et al., International Journal of Biological Macromolecules, 238 (2023), 124085 (6 MB)

Virology Related

Iota-carrageenan extracted from red algae is a potent inhibitor of SARS‐CoV-2 infection in reconstituted human airway epithelia

Bovard et al., Biochemistry and Biophysics Reports, Volume 29, 2022, 101187 (3 MB)

Virology Related

Efficacy of a Nasal Spray Containing Iota-Carrageenan in the Postexposure Prophylaxis of COVID-19 in Hospital Personnel Dedicated to Patients Care with COVID-19 Disease

Figueroa et al., Int J Gen Med. 2021;14:6277-6286 (3 MB)

Virology Related

Griffithsin and Carrageenan Combination Results in Antiviral Synergy against SARS-CoV-1 and 2 in a Pseudoviral Model

Alsaidi et al., Mar. Drugs 2021, 19, 418. (530 KB)

Virology Related

Lectin from Triticum vulgaris (WGA) Inhibits Infection with SARS-CoV-2 and Its Variants of Concern Alpha and Beta

Auth, J. et al., Int. J. Mol. Sci. 2021, 22, 10205. (2 MB)

Virology Related

Carrageenan nasal spray may double the rate of recovery from coronavirus and influenza virus infections: Re-analysis of randomized trial data

Hemilä et al., Pharmacology Research & Perspectives 2021; DOI: 10.1002/prp2.810 (759 KB)

Virology Related

PVP-I and Iota-Carrageenan Improve Subjective Clinical Symptoms In COVID-19 Emergency Hospital Wisma Atlet, Indonesia: A Single-Blind Randomized Clinical Trial.

Amtha et al., Teikyo Medical Journal; 2021, 44 (05), 1659-1669 (270 KB)

Bansal et al., PLoS ONE 2021; 16(11): e0259943. (1 MB)

Virology Related

A randomized trial - intensive treatment based in Ivermectin and Iota-Carrageenan as pre-exposure prophylaxis for Covid-19 in healthcare agents

Chahla et al., medRxiv 2021; 03.26.21254398; doi: https://doi.org/10.1101/2021.03.26.21254398 (198 KB)

Virology Related

Natural Derived Nasal Spray; A Proposed Approach for COVID-19 Disease Control

Hoseini-Tavassol et al., Infectious Disorders - Drug Targets, 2021, 20, 1-7 (527 KB)

Virology Related

Nasal therapy — The missing link in optimising strategies to improve prevention and treatment of COVID-19

Ratcliffe et al., PLoS Pathog 2021; 17(11): e1010079 (355 KB)

Virology Related

Safety and efficacy of iota-carrageenan nasal spray in treatment and prevention of the common cold

Bichiri et al., Med Pharm Rep. 2021 Jan; 94(1): 28–34. (395 KB)

Virology Related

Carrageenan containing over-the-counter nasal and oral sprays inhibit SARS-CoV-2 infection of airway epithelial cultures

Schütz et al., American Journal of Physiology-Lung Cellular and Molecular Physiology, 2021 (517 KB)

Kramer et al., GMS Hygiene and Infection Control 2021, Vol. 16, ISSN 2196-5226 (157 KB)

Eccles, The Open Virology Journal 2020, 14:9 (3 MB)

Virology Related

Study of the Efficacy and Safety of Topical Ivermectin + Iota-Carrageenan in the Prophylaxis against COVID-19 in Health Personnel

Carvallo et al., Journal of Biomedical Research and Clinical Investigation 2020; Volume 2 Isue 1.1007 (600 KB)

Virology Related

The COVID 19 novel coronavirus pandemic 2020: seaweeds to the rescue? Why does substantial, supporting research about the antiviral properties of seaweed polysaccharides seem to go unrecognized by the pharmaceutical community in these desperate times?

Pereira, L., Critchley, A.T., Journal of Applied Phycology 2020 (193 KB)

Lee, Marine Drugs 2020, 18, 435 (664 KB)

Bansal et al., bioRxiv. 2020; 10.1101/2020.08.19.225854 (348 KB)

Virology Related

Application prospect of polysaccharides in the development of anti-novel coronavirus drugs and vaccines

Chen et al., International Journal of Biological Macromolecules, 2020, 164, 331-343 (3 MB)

Hirsch et al., Journal of Infectious Diseases & Travel Medicine 2020, 4 (S1): 000S1-007 (229 KB)

Virology Related

Efficacy and safety of iota-carrageenan nasal spray versus placebo in early treatment of the common cold in adults: the ICICC trial

Eccles et al., Respiratory Research 2015, 16:121 (914 KB)

ALL
2024
2023
2020
2019
2010

Immunology Marinomed

Alleviation of allergic rhinoconjunctivitis symptoms in participants treated with a 0.005% tacrolimus eye drop solution

Sladek, S. et al., Clin Ophthalmol. 2024;18:2797-2811; doi: https://doi.org/10.2147/OPTH.S476163 (3 MB)

Immunology Marinomed

Decongestant Effect of “Coldamaris Akut”, a Carrageenan- and Sorbitol-Containing Nasal Spray in Seasonal Allergic Rhinitis

Unger-Manhart N, Morokutti-Kurz M, Zieglmayer P, Russo A, Siegl C, König-Schuster M, Koller C, Graf P, Graf C, Lemell P,… (703 KB)

Immunology Marinomed

Carrageenan-Containing Nasal Spray Alleviates Allergic Symptoms in Participants with Grass Pollen Allergy: A Randomized, Controlled, Crossover Clinical Trial

Unger-Manhart, N. et al., Int J Gen Med. 2024;17:419-428 (2 MB)

Immunology Marinomed

Decongestant effect of treatment with sorbitol-containing Carragelose® nasal spray (Poster)

N. Unger-Manhart et al., 2023 (146 KB)

Immunology Marinomed

Carragelose® nasal spray is effective in reducing allergic nasal symptoms (Poster)

N. Unger-Manhart et al. 2023 (158 KB)

Immunology Marinomed

Carrageenan-containing nasal spray alleviates allergic symptoms in subjects with grass pollen allergy: A randomized, controlled, crossover clinical trial

Unger-Manhart et al., medRxiv 2023.10.19.23297206; doi: https://doi.org/10.1101/2023.10.19.23297206 (332 KB)

Immunology Marinomed

Saponin Micelles Lead to High Mucosal Permeation and In Vivo Efficacy of Solubilized Budesonide

Nakowitsch et al., Pharmaceutics 2020, 12(9), 847 (1 MB)

Immunology Marinomed

Topical Pergolide Enhance Corneal Nerve Regrowth Following Induced Corneal Abrasion

Zhang et al., Invest Ophthalmol Vis Sci. 2020; 61(1):4. (2 MB)

Immunology Marinomed

Fast effectiveness of a solubilized low‐dose budesonide nasal spray in allergic rhinitis

Zieglmayer et al., Clin Exp Allergy. 2020; 00:1–13. (1 MB)

Immunology Marinomed

Pharmacokinetics of topically applied tacrolimus dissolved in Marinosolv, a novel aqueous eye drop formulation

Siegl et al., European Journal of Pharmaceutics and Biopharmaceutics 134, 2019, 88-95 (5 MB)

Immunology Marinomed

Beta-escin has potent anti-allergic efficacy and reduces allergic airway inflammation

Lindner, I. et. al.BMC Immunol. 2010 May 21;11:24. doi: 10.1186/1471-2172-11-24 (2 MB)

ALL
2014

Immunology Related

Non-Invasive Optical Imaging of Eosinophilia during the Course of an Experimental Allergic Airways Disease Model and in Response to Therapy

Markus et al., PLOS one 2014, 9:2 (3 MB)

Lucia Ziegler, MSc

Head of Investor & Public Relations

+ 43 2262 90300 pr@marinomed.com

Marinomed Biotech AG
Hovengasse 25
2100 Korneuburg, Austria
+43 2262 90300
office@marinomed.com